IILIC

����

LIFE INSURANCE CORPORATION Of INOIA

Date:

July 25

, 2022

Ref. No.: LIC/SE/2022-23/41

1h

To,

The Manager

The Manager

Listing Department

Listing Department

Exchange of India Ltd.

BSE Limited

The National Stock

Phiroze Jeejeebhoy Tower

th

Floor, Plot

C/1,

NSE - LICI)

Exchange Plaza, 5

Dalal Street

G Block, Sandra Kurla Complex

ScripCode: (BSE - 543526/

Mumbai - 400051

Mumbai- 400001

Dear Sir/Madam,

Sub: Intimation under Regulation 30

(Listing Obligations and Disclosure

Shares

of the Securities and Exchange Board of India Requirements) Regulations, 2015 - Sale of

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)

Regulations, 2015, this

is

to

inform that Corporation's shareholding

in

"SUN

PHARMACEUTICALS INDUSTRIES LTD" has diluted from 16,85,66,486 to 12,05,24,944

Equity Shares decreasing its shareholding from 7.026% to 5.024% of the paid-up capital

of the said Company.

The details as required under SEBI (Listing Obligations and Disclosure Requirements�

1

Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9

September, 2015 are enclosed as "Annexure - A".

This is for your information and dissemination.

For Life Insurance Corporation of India

Y urs faithf lly,

(Pa�t1°�1;}>

Officer

Company Secretary & C

liance

��. �.��1ll'f.!M- 400021. �: 88598000

Central office, "Yogakshema", Jeevan Bima Marg, Mumbai - 400 021,

Tel.: 66598000

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

LIC - Life Insurance Corporation of India published this content on 25 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 July 2022 12:03:07 UTC.